Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Description

The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.

Conditions

Prostate Cancer

Study Overview

Study Details

Study overview

The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.

Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to Enhance MRI Diagnostic Capabilities in Prostate Cancer

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Condition
Prostate Cancer
Intervention / Treatment

-

Contacts and Locations

San Antonio

Audie Murphie VA, San Antonio, Texas, United States, 78229

San Antonio

The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center, San Antonio, Texas, United States, 78229

San Antonio

University Health System, San Antonio, Texas, United States, 78229

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Selected to undergo an MRI-fusion prostate needle biopsy of the prostate.
  • * Able to provide informed consent
  • * prior diagnosis of prostate cancer (Grade Group \>1)
  • * metastatic prostate cancer
  • * prior prostate cancer treatment
  • * contraindication to prostate biopsy (e.g., on anticoagulation that cannot be safely discontinued)
  • * inability to undergo MRI (e.g., too large to be accommodated in a scanner or with an implant incompatible with MRI).
  • * Bilateral hip replacement
  • * Unable to provide informed consent.

Ages Eligible for Study

to

Sexes Eligible for Study

MALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

The University of Texas Health Science Center at San Antonio,

Michael A Liss, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Texas Health Science Center San Antonio

Study Record Dates

2028-04